Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Stock Short Interest Climbs 253.8%

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 92 shares, an increase of 253.8% from the August 31st total of 26 shares. Based on an average daily volume of 74 shares, the short-interest ratio is presently 1.2 days. Currently, 0.0% of the company’s shares are short sold.

Wall Street Analyst Weigh In

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 15th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of “Hold”.

Get Ambu A/S alerts:

Check Out Our Latest Analysis on AMBBY

Ambu A/S Stock Performance

Shares of Ambu A/S stock opened at $10.22 on Friday. Ambu A/S has a 52 week low of $8.54 and a 52 week high of $16.78. The business’s fifty day simple moving average is $10.80 and its 200-day simple moving average is $10.39. The firm has a market cap of $2.40 billion, a PE ratio of 34.08 and a beta of 0.93. The company has a quick ratio of 1.73, a current ratio of 2.77 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its quarterly earnings data on Tuesday, August 25th. The company reported $0.09 earnings per share (EPS) for the quarter. The firm had revenue of $255.12 million during the quarter. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Company Profile

(Get Free Report)

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring.

Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics.

See Also

• Five stocks we like better than Ambu A/S
• 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
• SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
• These 3 Overlooked Stocks Have Big Money Behind Them
• Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.